![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
2B- and
2-Adrenoceptor Activation Sensitizes the
2B-Adrenoceptor for Agonist-Induced Down-Regulation
Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas
We recently reported that
2A-adrenoceptor (AR) desensitization and down-regulation occurs after 24-h treatment with epinephrine (EPI) (0.3 µM) in BE(2)-C cells that express both
2- and
2-ARs. The same concentration of norepinephrine (NE) has no effect. The effect of EPI is prevented by
2-AR blockade and is associated with an increase in G protein-coupled receptor kinase 3 (GRK3) expression. Because differences in agonist-induced down-regulation of the
2A-versus
2B-ARs have been reported, the present study examines the effects of simultaneous activation of
2B- and
2-ARs on
2B-AR number and signaling. We studied NG108 cells that naturally express
2B-ARs, and BN17 cells, NG108 cells transfected to express the human
2-AR. In NG108 cells,
2B-AR desensitization and down-regulation require treatment with 20 µM EPI or NE; GRK expression was not changed. In BN17 cells expressing
2-ARs, the threshold EPI concentration for
2B-AR desensitization and down-regulation was reduced to 0.3 µM; 10 µM NE was required for the same effect. Furthermore, 24-h EPI or NE treatments that produced desensitization also resulted in a selective 2-fold up-regulation of GRK3; GRK2 was unchanged. The
-AR antagonist alprenolol (1 µM) and GRK3 antisense (but not sense) DNA blocked 0.3 µM EPI- and 10 µM NE-induced desensitization and down-regulation of the
2B-AR as well as GRK3 up-regulation. In conclusion, simultaneous activation of
2B- and
2-ARs results in a 67-fold decrease in the threshold concentration of EPI required for
2B-AR down-regulation. This lower threshold for down-regulation is associated with
2B- and
2-AR dependent up-regulation of GRK3 expression.
Address correspondence to: Dr. Douglas C. Eikenburg, Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204-5037. E-mail: deikenburg{at}uh.edu
This article has been cited by other articles:
![]() |
S. Salim, K. M. Standifer, and D. C. Eikenburg Extracellular Signal-Regulated Kinase 1/2-Mediated Transcriptional Regulation of G-Protein-Coupled Receptor Kinase 3 Expression in Neuronal Cells J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 51 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Salim and D. C. Eikenburg Role of 90-kDa Heat Shock Protein (Hsp 90) and Protein Degradation in Regulating Neuronal Levels of G Protein-Coupled Receptor Kinase 3 J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1106 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Desai, S. Salim, K. M. Standifer, and D. C. Eikenburg Involvement of G Protein-Coupled Receptor Kinase (GRK) 3 and GRK2 in Down-Regulation of the {alpha}2B-Adrenoceptor J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1027 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Desai, K. M. Standifer, and D. C. Eikenburg Cellular G Protein-Coupled Receptor Kinase Levels Regulate Sensitivity of the {alpha}2B-Adrenergic Receptor to Undergo Agonist-Induced Down-Regulation J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 767 - 773. [Abstract] [Full Text] [PDF] |
||||